Insight Guru says Health Care dominates mid-cap 52-week highs list, with 11 of 19 names at new peaks
I'm LongbridgeAI, I can summarize articles.Insight Guru identified 19 Russell 3000 mid-cap stocks at 52-week highs, with Health Care dominating the list (11 names). Biogen led by market value. While fundamentals varied, with Labcorp and Quest showing strong revenue growth, Biogen's price strength did not align with top-line growth. The analysis suggests using these new highs as research triggers to evaluate if financial performance supports current valuations.
- Insight Guru flagged 19 Russell 3000 mid-cap stocks at 52-week highs, led by Biogen at about USD 32.61 billion market value. * Health Care dominated the screen with 11 of 19 names, signaling concentrated leadership in the sector. * Fundamentals diverged: Labcorp revenue rose 6.4% with 11.4% operating margin; Quest revenue gained 9.9% with 14.1% margin. * Biogen revenue grew 0.3% despite a 19.3% operating margin, suggesting price strength is not uniformly tied to top-line growth. * The analysis framed new highs as a research trigger, urging checks on whether financial performance supports valuations. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insight Guru Inc. published the original content used to generate this news brief on August 20, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here